Figure-03 (Clopidogrel Fig 3)
Clopidogrel
Product Images NDC 70786-0060
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Clopidogrel (NDC 70786-0060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1 (Clopidogrel Figure 01)
Figure-2 (Clopidogrel Figure 02)
This is a chart presenting information on the effectiveness of two types of treatments marked as PLACEBO (+ aspirin) and CLOPIDOGREL (+ aspirin) over a period of 12 months. The lower value of 0.00009 suggests that CLOPIDOGREL (+ aspirin) might be a more effective treatment option. The chart indicates that other standard therapies were included when necessary.*
Figure-4 (Clopidogrel Figure 04)
This appears to be a report on the effectiveness of a drug called Clopidogrel compared to a placebo in reducing the number of deaths in patients. The report shows that 1845 patients who took the placebo died, which is 8.1% of those who received it, compared to 1726 patients who took Clopidogrel and died, which is only 7.5% of those who received it. The text highlights that there was a 7% proportional risk reduction with the use of Clopidogrel, and that all treated patients also received aspirin. The report shows a graph (with the letters T and numbers) that appears to represent the days since the study started.*
Figure-5 (Clopidogrel Figure 05)
Fig-7 (Clopidogrel Figure 07)
This is a report for a medical study that tested the effectiveness of aspirin and clopidogrel for an unknown medical condition. The study lasted for several months and had a statistically significant result that is denoted by the p-value of 0.045. No other information about the study or its findings is available.*
Figure-3 (Clopidogrel Figure 3)
Figure-6 (Clopidogrel Figure 6)
Figure-8 (Clopidogrel Figure 8)
Structure (Clopidogrel Structure)
Label Image (Lbl707860060)
CLOPIDOGREL BISULFATE 75 MG / 30 TAB is a drug manufactured by MACLEODS PHARMA LTD in India. It contains 97.675 ng of Clopidogrel Bisulfate, 2775 mg of Clopadogeel Base and is controlled. It comes in a package sold by Unit Dose Services, LLC and has an NDC of 70786-0060-1. The lot number is not explicitly stated. The drug is prescription-only and is marked with RXONLY.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
